Immunotherapy drugs boosts the body’s natural defenses to fight various diseases. It uses substances made by the body or in a laboratory to improve or restore immune system function. Immunotherapy may work either by stopping or slowing the growth of diseased cells, stopping disease from spreading to other parts of the body, or helping the immune system work better at destroying affected cells. Immune checkpoint inhibitors are drugs, often made of antibodies that unleash an immune system attack on cancer cells. Three checkpoint inhibitors have received rapid approval from the U.S. Food and Drug Administration for cancer, including ipilimumab (Yervoy), pembrolizumab (Keytruda), and nivolumab (Opdivo). Cell-based immunotherapies are effective for some cancers. Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. By targeting surface antigens expressed on tumor cells, monoclonal antibodies have demonstrated efficacy as cancer therapeutics. Antimicrobial immunotherapy, which includes vaccination, involves activating the immune system to respond to an infectious agent.
The global immunotherapy drugs market segmentation is based on drug type (checkpoint inhibitors, interferons, interleukins, monoclonal antibodies, vaccines, others), and disease type (autoimmune and inflammatory diseases, cancer, infectious diseases, others).
The global immunotherapy drugs market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global immunotherapy drugs market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World. The global immunotherapy drugs market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global immunotherapy drugs market and profiled in this report include Amgen Inc., F. Hoffmann-La Roche AG, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Inc., and Novartis International AG.